HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kelly K Hunt Selected Research

Breast Neoplasms (Breast Cancer)

6/2022National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer.
3/2022Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
1/2022Editorial on Toesca et al's "A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BRCA Mutation".
1/2022Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).
1/2022Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.
1/2022The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
10/2021Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
10/2021Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
9/2021Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers.
8/2021Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kelly K Hunt Research Topics

Disease

241Breast Neoplasms (Breast Cancer)
06/2022 - 01/2002
200Neoplasms (Cancer)
06/2022 - 01/2002
37Neoplasm Metastasis (Metastasis)
01/2019 - 05/2002
23Sarcoma (Soft Tissue Sarcoma)
10/2022 - 09/2002
21Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019 - 11/2002
17Pathologic Complete Response
10/2021 - 01/2002
14Carcinoma (Carcinomatosis)
07/2020 - 05/2002
12Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2022 - 01/2016
11Triple Negative Breast Neoplasms
04/2021 - 10/2011
9Disease Progression
01/2022 - 08/2003
9Melanoma (Melanoma, Malignant)
09/2018 - 04/2002
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2014 - 12/2003
8Lobular Carcinoma
01/2021 - 10/2006
8Leiomyosarcoma
01/2017 - 11/2005
7Lung Neoplasms (Lung Cancer)
01/2018 - 04/2002
7Necrosis
12/2013 - 05/2004
6Lymphoma (Lymphomas)
12/2021 - 11/2004
6Lymphatic Metastasis
04/2016 - 04/2008
5T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 01/2016
5Margins of Excision
12/2018 - 02/2003
5Inflammatory Breast Neoplasms
02/2017 - 07/2007
5Carcinogenesis
01/2016 - 11/2004
4Lymphedema (Milroy Disease)
02/2019 - 10/2006
4Residual Neoplasm
01/2018 - 10/2006
4Infections
08/2014 - 08/2005
4Genomic Instability
01/2011 - 11/2006
4Ductal Carcinoma
06/2009 - 10/2006
3Liposarcoma
01/2022 - 04/2015
3Hemangiosarcoma (Angiosarcoma)
01/2021 - 12/2005
3Postoperative Pain
03/2020 - 09/2009
3Neoplasm Micrometastasis
01/2018 - 09/2003
3Lymphadenopathy
12/2017 - 02/2011
3Unilateral Breast Neoplasms
03/2011 - 01/2005
3Anaphylaxis (Anaphylactic Shock)
04/2006 - 02/2004

Drug/Important Bio-Agent (IBA)

38Estrogen ReceptorsIBA
01/2019 - 10/2003
22Proteins (Proteins, Gene)FDA Link
01/2016 - 12/2002
19Cyclin EIBA
05/2021 - 08/2005
18Biomarkers (Surrogate Marker)IBA
05/2021 - 12/2002
17Hormones (Hormone)IBA
01/2022 - 08/2005
16Progesterone Receptors (Progesterone Receptor)IBA
08/2018 - 04/2002
15Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 01/2002
13Biological ProductsIBA
08/2018 - 11/2004
10Trastuzumab (Herceptin)FDA Link
12/2013 - 08/2004
8Biological FactorsIBA
07/2020 - 07/2016
8Paclitaxel (Taxol)FDA LinkGeneric
12/2013 - 04/2002
7Phosphotransferases (Kinase)IBA
04/2021 - 06/2004
7AnthracyclinesIBA
01/2021 - 08/2002
7Coloring Agents (Dyes)IBA
12/2020 - 02/2004
7Protein Isoforms (Isoforms)IBA
10/2018 - 06/2004
7Estrogens (Estrogen)FDA Link
08/2018 - 04/2002
7Fluorouracil (Carac)FDA LinkGeneric
12/2013 - 06/2005
7Imatinib Mesylate (Gleevec)FDA Link
01/2012 - 12/2003
6Capsules (Microcapsules)IBA
12/2021 - 01/2016
6human ERBB2 proteinIBA
10/2017 - 06/2005
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2013 - 06/2005
6eIF-2 Kinase (eIF 2 Kinase)IBA
08/2008 - 04/2002
6iso-sulfan blue (Lymphazurin)FDA LinkGeneric
04/2006 - 01/2003
6Double-Stranded RNA (RNA, Double Stranded)IBA
11/2005 - 04/2002
5palbociclibIBA
01/2022 - 01/2017
5Pharmaceutical PreparationsIBA
01/2016 - 04/2003
5ElafinIBA
06/2015 - 12/2007
5TamoxifenFDA LinkGeneric
08/2010 - 01/2002
5CytokinesIBA
02/2007 - 05/2002
4Taxoids (Taxanes)IBA
01/2021 - 10/2008
4taxaneIBA
01/2021 - 12/2009
4Phenobarbital (Luminal)FDA Link
01/2020 - 12/2010
4Cytostatic AgentsIBA
01/2020 - 09/2010
4DNA (Deoxyribonucleic Acid)IBA
12/2018 - 11/2006
4Epirubicin (Ellence)FDA LinkGeneric
12/2013 - 06/2005
4ParaffinIBA
07/2013 - 01/2004
4E2F1 Transcription FactorIBA
03/2010 - 04/2003
3Aromatase InhibitorsIBA
01/2022 - 02/2010
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 01/2017
3EnzymesIBA
01/2018 - 10/2009
3ErbB Receptors (EGF Receptor)IBA
10/2016 - 06/2005
3RoscovitineIBA
01/2012 - 10/2008
3Eosine Yellowish-(YS) (Eosin)IBA
07/2011 - 04/2005
3Hematoxylin (Haematoxylon)IBA
07/2011 - 04/2005
3Complement System Proteins (Complement)IBA
01/2011 - 02/2007
3Interleukin-10 (Interleukin 10)IBA
02/2007 - 01/2004
3interleukin-24 (ST16)IBA
02/2007 - 08/2003
3LuciferasesIBA
08/2005 - 04/2003

Therapy/Procedure

109Therapeutics
06/2022 - 01/2002
81Neoadjuvant Therapy
03/2022 - 01/2002
59Segmental Mastectomy (Lumpectomy)
01/2022 - 03/2002
57Radiotherapy
01/2022 - 04/2002
54Drug Therapy (Chemotherapy)
10/2021 - 04/2002
46Mastectomy (Mammectomy)
01/2022 - 01/2002
30Lymph Node Excision (Lymph Node Dissection)
10/2022 - 01/2003
12Breast Implants (Breast Implant)
09/2022 - 01/2016
11Mammaplasty (Breast Reconstruction)
01/2019 - 05/2002
10Adjuvant Chemotherapy
01/2021 - 07/2002
6Contraindications
01/2022 - 01/2006
6Aftercare (After-Treatment)
04/2021 - 01/2007
6Surgical Instruments (Clip)
01/2019 - 12/2007
6Brachytherapy
01/2019 - 05/2011
6Prophylactic Mastectomy
01/2018 - 10/2006
4Simple Mastectomy
03/2011 - 03/2004
3Operative Surgical Procedures
10/2016 - 03/2003
3Catheters
08/2014 - 02/2004